Lanfeng Biochemical disclosed an earnings forecast, expecting a net loss attributable to the parent of 45 million to 75 million yuan in the first half of 2026, compared with a loss of 44.7789 million yuan in the same period last year. The net loss after deducting non-recurring items is expected to be 47 million to 77 million yuan, compared with a loss of 46.5636 million yuan a year earlier. Basic loss per share is estimated at 0.12 to 0.2 yuan. The company's losses mainly stem from an asset impairment provision of approximately 39.0786 million yuan, share-based payment expenses of about 40.07 million yuan from the restricted stock incentive plan, as well as the agrochemical segment not yet turning profitable and the new energy segment's earnings falling short of expectations. Lanfeng Biochemical's main business is divided into two major segments: pesticide chemicals and new energy photovoltaics.
Jiangsu Lanfeng Bio-chemical Co LtdExpects wider net loss in H1 2026 due to asset impairment, share-based payment expenses, and underperformance in agrochemical and new energy segments.